"Presence of Comorbidities and Use of Concomitant Medications Associated with QTC Prolongation/torsades de pointes in Patients with HR+/HER2- advanced Breast Cancer" by Reshma Mahtani

Article

Presence of Comorbidities and Use of Concomitant Medications Associated with QTC Prolongation/torsades de pointes in Patients with HR+/HER2- advanced Breast Cancer

Cancer Research / San Antonio Breast Cancer Symposium (2021)

Reshma Mahtani, Baptist Health South Florida

Link

Abstract

K. Lewis; E. Clayton; M. Last; D. Mitra; S.K. Kurosky

Disciplines

Medicine and Health Sciences

Publication Date

February 15, 2021

Citation Information

Reshma Mahtani. "Presence of Comorbidities and Use of Concomitant Medications Associated with QTC Prolongation/torsades de pointes in Patients with HR+/HER2- advanced Breast Cancer" Cancer Research / San Antonio Breast Cancer Symposium Vol. 81 Iss. 4 Supplement (2021)
Available at: http://works.bepress.com/reshma-mahtani/45/